Healthcare Providers and Services
Company Overview of Joslin Diabetes Center, Inc.
Joslin Diabetes Center, Inc. operates a diabetes treatment, research, and education institution. It offers research programs for preventing and curing type 1 and type 2 diabetes and their long-term complications. The company also provides diabetes care services for adult and pediatric patients. In addition, it develops and markets programs, products, and services for the availability of the company’s knowledge and expertise to people with diabetes and the clinicians caring for them. Joslin Diabetes Center, Inc. was founded in 1898 and is headquartered in Boston, Massachusetts.
One Joslin Place
Boston, MA 02215
Founded in 1898
Key Executives for Joslin Diabetes Center, Inc.
Senior Vice President of Medical Affairs
Compensation as of Fiscal Year 2014.
Joslin Diabetes Center, Inc. Key Developments
Joslin Diabetes Center Introduces Joslin Institute for Technology Translation
Jun 10 14
Joslin Diabetes Center announced the introduction of the Joslin Institute for Technology Translation, a new division of Joslin Diabetes Center that formalizes the delivery of Joslin's clinical solutions to medical device and technology companies. In addition, it was announced that Dexcom, Inc., a San Diego-based maker of continuous glucose monitoring systems for patients and blood glucose monitoring systems for healthcare providers in hospital settings, has joined to become the first Founding Member of the JITT and is a member of the Institute's Advisory Board. The mission of the Joslin Institute for Technology Translation will focus on four key areas: Create and offer physician-designed, and patient-tested, decision support tools for improved solutions in glucose and insulin management; Be a powerful voice in moving digital health to improve diabetes care in a cost-effective approach -- collaborating with numerous medical device and technology organizations; Create individualized, confidential collaborations with industry partners providing new solutions that advances the monitoring and treatment of diabetes via new technologies; and Pioneer innovative education and training programs that optimize decision-making processes and the adoption of best-in-class technologies for healthcare professionals and patients world-wide.
Joslin Diabetes Center, Inc. Presents at Boston Biotech BD Boston Conference, Mar-25-2014 01:40 PM
Mar 14 14
Joslin Diabetes Center, Inc. Presents at Boston Biotech BD Boston Conference, Mar-25-2014 01:40 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: John L. Brooks, Chief Executive Officer, President and Trustee.
Joslin Diabetes Center, Inc. Elects Five New Members to its Board of Trustees
Jan 14 14
Joslin Diabetes Center announced that five new members have been elected to its Board of Trustees: Michael Astrue, former Commissioner of Social Security; James Geraghty, Entrepreneur-in-Residence at Third Rock Ventures, LLC; Roberta Herman, MD, former Chief Operating Officer of Harvard Pilgrim Health Care, Inc.; Jessica Hopfield, PhD, former partner, McKinsey & Company; and Barry Libert, Chief Executive Officer of OpenMatters. Dr. Roberta Herman served as Chief Operating Officer of Harvard Pilgrim Health Care from 2010 to 2013. Barry Libert has spent the last decade founding, investing in, and advising social software and analytics companies, including Mzinga, Innocentive, The Pulse Network, MedNetworks, and many more.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|